GeneDx, a fast-growing biotech doing exome and genomic testing, has seen big returns on Wall Street as appetite for its tests grow in the clinic.

Knowable Magazine reports 2025 faced turmoil in U.S. science amid job cuts and budget slashes, yet saw advances in gene ...

AlphaGenome is a leap forward in the ability to study the human blueprint. But the fine workings of our DNA are still largely ...

Scientists at Google DeepMind —the company’s artificial intelligence research arm—say they’ve created an A.I. tool that can ...

Google unveiled an artificial intelligence tool Wednesday that its scientists said would help unravel the mysteries of the human genome—and could one day lead to new treatments for diseases.

DeepMind’s AlphaGenome AI model could help solve the problem of predicting how variations in noncoding DNA shape gene ...

Ambry Genetics, a leader in clinical genomic testing, and now a wholly owned subsidiary of Tempus AI, Inc. , today announced its contribution to new research leveraging Multiplexed Assays of Variant ...

The history of genomics has long been a story of reading a book where only every fiftieth page made sense. While the Human ...